000			01514 a2200397 4500
005			20250513091849.0
264		0	_c19960808
008			199608s 0 0 eng d
022			_a1073-449X
024	7		_a10.1164/ajrccm.153.6.8665057 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhu, J
245	0	0	_aImmunologic alterations in bleomycin-treated mice: role of pulmonary fibrosis in the modulation of immune responses. _h[electronic resource]
260			_bAmerican journal of respiratory and critical care medicine _cJun 1996
300			_a1924-30 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aBleomycin _xadverse effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCells, Cultured _xdrug effects
650	0	4	_aFemale
650	0	4	_aHydroxyproline _xdrug effects
650	0	4	_aInterleukin-2 _xmetabolism
650	0	4	_aLymphocyte Subsets _xdrug effects
650	0	4	_aLymphocytes _xcytology
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C57BL
650	0	4	_aPhenotype
650	0	4	_aPulmonary Fibrosis _xchemically induced
650	0	4	_aSpleen _xcytology
700	1		_aKaplan, A M
700	1		_aGoud, S N
773	0		_tAmerican journal of respiratory and critical care medicine _gvol. 153 _gno. 6 Pt 1 _gp. 1924-30
856	4	0	_uhttps://doi.org/10.1164/ajrccm.153.6.8665057 _zAvailable from publisher's website
999			_c8663376 _d8663376